5,874 reports of this reaction
3.9% of all DOCETAXEL ANHYDROUS reports
#4 most reported adverse reaction
HAIR COLOUR CHANGES is the #4 most commonly reported adverse reaction for DOCETAXEL ANHYDROUS, manufactured by Hospira, Inc.. There are 5,874 FDA adverse event reports linking DOCETAXEL ANHYDROUS to HAIR COLOUR CHANGES. This represents approximately 3.9% of all 152,096 adverse event reports for this drug.
Patients taking DOCETAXEL ANHYDROUS who experience hair colour changes should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAIR COLOUR CHANGES is moderately reported among DOCETAXEL ANHYDROUS users, representing a notable but not dominant share of adverse events.
In addition to hair colour changes, the following adverse reactions have been reported for DOCETAXEL ANHYDROUS:
The following drugs have also been linked to hair colour changes in FDA adverse event reports:
HAIR COLOUR CHANGES has been reported as an adverse event in 5,874 FDA reports for DOCETAXEL ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAIR COLOUR CHANGES accounts for approximately 3.9% of all adverse event reports for DOCETAXEL ANHYDROUS, making it a notable side effect.
If you experience hair colour changes while taking DOCETAXEL ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.